2025年至今,减重和相关产品话题一直热度不减,今年亦是国家多个部委联动启动的体重管理年。与此热度一样的则是多年来家长们一直关注的与儿童生长发育相关的生长激素产品,从不久前的第二十四届儿科内分泌遗传代谢病学术会议期间人头攒动的维升药业和其它国内外长效生长激素厂商的展台即可窥见一斑,长效生长激素已经是本次会议上来自全国的儿童内分泌医生关注的焦点之一。在这次会议的“从TransCon技术平台看全球长效...
Source Link2025年至今,减重和相关产品话题一直热度不减,今年亦是国家多个部委联动启动的体重管理年。与此热度一样的则是多年来家长们一直关注的与儿童生长发育相关的生长激素产品,从不久前的第二十四届儿科内分泌遗传代谢病学术会议期间人头攒动的维升药业和其它国内外长效生长激素厂商的展台即可窥见一斑,长效生长激素已经是本次会议上来自全国的儿童内分泌医生关注的焦点之一。在这次会议的“从TransCon技术平台看全球长效...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.